| Primary |
| Seasonal Allergy |
41.7% |
| Rhinitis Allergic |
25.0% |
| Sinus Disorder |
16.7% |
| Nasal Congestion |
8.3% |
| Nasal Polyps |
8.3% |
|
| Optic Nerve Disorder |
22.2% |
| Sinus Disorder |
22.2% |
| Anosmia |
11.1% |
| Drug Ineffective |
11.1% |
| Grand Mal Convulsion |
11.1% |
| Psychotic Disorder |
11.1% |
| Visual Acuity Reduced |
11.1% |
|
| Secondary |
| Diabetes Mellitus |
15.5% |
| Oedema |
13.4% |
| Alanine Aminotransferase Increased |
11.3% |
| Oedema Peripheral |
10.3% |
| Hepatic Enzyme Increased |
7.2% |
| Blood Cholesterol Increased |
5.2% |
| Myalgia |
5.2% |
| Rhinitis |
5.2% |
| Rhinitis Allergic |
4.1% |
| Cough |
3.1% |
| Fluid Retention |
3.1% |
| Respiratory Tract Infection Viral |
3.1% |
| Influenza |
2.1% |
| Liver Disorder |
2.1% |
| Muscle Spasms |
2.1% |
| Seasonal Allergy |
2.1% |
| Snoring |
2.1% |
| Chronic Sinusitis |
1.0% |
| Enzyme Abnormality |
1.0% |
| Hiv Infection |
1.0% |
|
| Oedema Peripheral |
27.3% |
| Treatment Noncompliance |
18.2% |
| Drug Hypersensitivity |
9.1% |
| Drug Ineffective |
9.1% |
| Drug Interaction |
9.1% |
| Inhibitory Drug Interaction |
9.1% |
| Optic Nerve Disorder |
9.1% |
| Pharmaceutical Product Complaint |
9.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.0% |
| Product Used For Unknown Indication |
10.0% |
| Breast Cancer |
9.1% |
| Hiv Infection |
8.9% |
| Hypertension |
7.5% |
| Asthma |
5.4% |
| Anxiety |
4.0% |
| Rhinitis Allergic |
4.0% |
| Pain |
3.5% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Parkinson's Disease |
3.3% |
| Breakthrough Pain |
3.2% |
| Bronchitis |
3.2% |
| Eustachian Tube Dysfunction |
2.1% |
| Panic Disorder |
2.1% |
| Prophylaxis |
2.1% |
| Restless Legs Syndrome |
2.1% |
| Sinusitis |
2.1% |
| Systemic Lupus Erythematosus |
2.1% |
| Insomnia |
1.9% |
|
| Tracheitis |
12.9% |
| Hepatitis |
9.7% |
| Weight Decreased |
9.7% |
| Vomiting |
7.5% |
| Oesophageal Stenosis |
4.3% |
| Pharmaceutical Product Complaint |
4.3% |
| Pulmonary Embolism |
4.3% |
| Spinal Compression Fracture |
4.3% |
| Spinal Osteoarthritis |
4.3% |
| Urinary Tract Infection |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Weight Increased |
4.3% |
| Deep Vein Thrombosis |
3.2% |
| Drug Ineffective |
3.2% |
| Fatigue |
3.2% |
| Myocardial Infarction |
3.2% |
| Pain |
3.2% |
| Pulmonary Hypertension |
3.2% |
| Skin Exfoliation |
3.2% |
| Sleep Apnoea Syndrome |
3.2% |
|
